Valion Bio, Inc. (VBIO)

NASDAQ: VBIO · Real-Time Price · USD

0.1660

+0.0434 (35.40%)

At close: Aug 24, 2026, 4:00 PM EDT

0.1446

-0.0214 (-12.89%)

After-hours: Aug 24, 2026, 6:47 PM EDT

Valion Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2.11	12.65	2	3.4	3.52	12.98
Cash & Short-Term Investments	2.11	12.65	2	3.4	3.52	12.98
Cash Growth	78.04%	531.62%	-41.03%	-3.47%	-72.89%	1142.82%
Receivables	-	-	-	0.17	0.11	0.09
Inventory	0.75	-	-	0.76	0.86	0.43
Prepaid Expenses	0.52	0.35	0.24	0.33	0.24	0.79
Other Current Assets	-	0.02	0.4	-	0.58	-
Total Current Assets	3.38	13.01	2.64	4.65	5.31	14.29
Property, Plant & Equipment	22.18	12.64	0	0.47	0.54	0.7
Goodwill	3.46	3.46	-	-	-	-
Other Intangible Assets	2.24	2.24	-	-	-	-
Long-Term Deferred Charges	0.63	0.14	0.05	-	-	-
Other Long-Term Assets	0.58	0.12	0.12	0.03	0.03	0.05
Total Assets	32.47	31.61	2.81	5.16	5.88	15.04

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.64	0.26	0.13	0.71	1.32	0.79
Accrued Expenses	1.83	0.38	0.13	0.49	0.39	0.25
Current Portion of Leases	0.53	-	-	0.19	0.16	0.16
Current Unearned Revenue	-	-	-	0.01	0	0.02
Other Current Liabilities	0.04	0.01	0.02	-	-	-
Total Current Liabilities	3.05	0.65	0.27	1.4	1.88	1.22
Long-Term Debt	7.39	6.45	-	-	-	-
Long-Term Leases	9.49	-	-	0.18	0.37	0.55
Other Long-Term Liabilities	8.31	7.71	-	-	-	-
Total Liabilities	28.23	14.81	0.27	1.58	2.25	1.76

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	-	-	0
Additional Paid-In Capital	70.75	69.39	46.08	41.47	33.27	32.82
Retained Earnings	-66.51	-52.6	-43.54	-37.89	-29.64	-19.55
Total Common Equity	4.25	16.8	2.54	3.58	3.63	13.27
Shareholders' Equity	4.25	16.8	2.54	3.58	3.63	13.27
Total Liabilities & Equity	32.47	31.61	2.81	5.16	5.88	15.04

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	17.41	6.45	-	0.37	0.53	0.71
Net Cash (Debt)	-15.3	6.19	2	3.03	2.99	12.27
Net Cash Growth	-	209.24%	-33.84%	1.31%	-75.65%	1311.62%
Net Cash Per Share	-6.69	5.36	6.97	64.87	-	-
Filing Date Shares Outstanding	22.19	2.88	0.62	0.09	0.02	-
Total Common Shares Outstanding	4.15	2.53	0.56	0.09	-	-
Working Capital	0.34	12.36	2.37	3.25	3.43	13.07
Book Value Per Share	1.02	6.65	4.55	41.51	-	-
Tangible Book Value	-1.45	11.1	2.54	3.58	3.63	13.27
Tangible Book Value Per Share	-0.35	4.39	4.55	41.51	-	-
Machinery	-	12.66	0.04	0.16	0.04	-

SEC Filings: 10-K · 10-Q